Unsurprisingly, many of these problems remain unresolved, including the category of screened patients now called CFSPID (CF Screen Positive, Inconclusive Diagnosis) in Europe and CFTR-related Metabolic Syndrome (CRMS) in the USA. The gene discussed is CFTR; the disease is metabolic syndrome.